What Is HGH? Research Evidence & Profile

What Is HGH?

Somatropin (HGH) is a 191-amino-acid human growth hormone entry identified as somatropin in the source record. This page identifies the material as Human Growth Hormone 191 Amino Acid (Somatropin). The Somatropin (HGH) identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation.

Evidence at a Glance

0ClinicalTrials.gov query records

85PubMed query records

6Selected publications shown

Sources: ClinicalTrials.gov query · PubMed query · Retrieved 2026-10-06

Mechanism & Pharmacology

The research record for Somatropin (HGH) is organized around growth-hormone receptor literature, protein and peptide characterization, endocrine-signaling research, and analytical macromolecule workflows. For Somatropin (HGH), those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.

Mechanistic or pathway language defines a research scope. It does not establish that a catalogue product produces a clinical effect.

Clinical Development

Selected exact-query registry records are shown below. Desktop displays up to six; mobile displays up to three.

NCT ID / Study	Phase	Status	Context	Last registry update
No exact-match registry records were returned by the displayed query at the retrieval time.

Source: ClinicalTrials.gov search · Retrieved 2026-10-06

Selected Literature6 important records shown

Selected Literature

Selected PubMed record

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

Handbook of experimental pharmacology · 2009

PMID 19089336

Selected PubMed record

Physiology, Growth Hormone (Archived).

Journal not stated · 2023 Jan

PMID 29489209

Selected PubMed record

Unconventional Uses of Human Growth Hormone.

Archives of medical research · 2026 Jul

PMID 41915988

Selected PubMed record

The Concept of Growth Hormone Deficiency Affecting Clinical Prognosis in IVF.

Frontiers in endocrinology · 2019

PMID 31636602

Selected PubMed record

Assays for human growth hormones.

Journal of pharmaceutical and biomedical analysis · 1989

PMID 2488617

Selected PubMed record

Short stature explained by dimerization of human growth hormone induced by a p.C53S point mutation.

The Journal of biological chemistry · 2020 Apr 10

PMID 32132170

Source: PubMed search results · Retrieved 2026-10-06

Identity & ChemistryProduct-form fields

Identity & Chemistry

Compound / Blend: Human Growth Hormone 191 Amino Acid (Somatropin)
Available Specifications: 8iu, 10iu, 12iu, 15iu, 24iu, 36iu, 40iu
Pack Format: 10 Vials

Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation.

Source: NOVABIO product identity record · No single PubChem record is asserted for this catalogue entry.

Research Tools for HGH

Review the selected registry records and open the module-level ClinicalTrials.gov query for the current result set.

Open Clinical Development

Use the complete NOVABIO documentation library to review currently available batch records.

Open Lab Results & COA

Storage & Laboratory HandlingDocumentation-led controls

Storage & Laboratory Handling

Confirm the exact material form, lot, supplied state and storage statement from the product label and corresponding batch documentation. Do not infer handling conditions from a different compound, strength or external clinical publication.

Regulatory Status

FDA-approved somatropin drug products exist for specific indications; NOVABIO catalogue material is not an FDA-approved drug.

Source: FDA Drugs@FDA · Checked 2026-10-06

Authoritative Data Summary

HGH Research Summary

Identity

Human Growth Hormone 191 Amino Acid (Somatropin); specifications: 8iu, 10iu, 12iu, 15iu, 24iu, 36iu, 40iu. Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation.

Mechanism

Evidence

0 registry records and 85 PubMed records were returned by the displayed query on 2026-10-06; counts are not quality ratings.

Regulatory context

FDA-approved somatropin drug products exist for specific indications; NOVABIO catalogue material is not an FDA-approved drug.

HGH is represented here by the catalogue identity Human Growth Hormone 191 Amino Acid (Somatropin). Identity fields describe the named catalogue record and must not be generalized to a different salt, counter-ion, hydrate or formulation. The product record lists 8iu, 10iu, 12iu, 15iu, 24iu, 36iu, 40iu as the currently available specifications. The research context is organized around this product-specific scope: The research record for Somatropin (HGH) is organized around growth-hormone receptor literature, protein and peptide characterization, endocrine-signaling research, and analytical macromolecule workflows. For Somatropin (HGH), those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome. The synchronized searches returned 0 ClinicalTrials.gov records and 85 PubMed records for the displayed query. A registry count includes records with different designs, statuses and populations, while a publication count can include reviews, preclinical work and unrelated uses of a shared abbreviation; neither count is a quality score. For regulatory interpretation, FDA-approved somatropin drug products exist for specific indications; NOVABIO catalogue material is not an FDA-approved drug. Clinical findings apply only to the studied drug product, formulation, population and protocol. NOVABIO product specifications and batch documentation are separate catalogue records and do not inherit clinical outcomes from external studies. This profile supports identity checking, source tracing and laboratory record review; it does not certify a batch, recommend treatment, provide dosing instructions or replace current official labeling and professional judgment.

Sources: PubMed · ClinicalTrials.gov · FDA · NOVABIO product record

FAQ4 evidence-bounded answers

HGH FAQ

What is HGH?

What research records are indexed for HGH?

The synchronized query returned 0 ClinicalTrials.gov records and 85 PubMed records on 2026-10-06; review the linked searches because counts and record status can change.

Is HGH FDA approved?

FDA-approved somatropin drug products exist for specific indications; NOVABIO catalogue material is not an FDA-approved drug.

Does this page provide dosing guidance?

No. This research profile provides identity, evidence, chemistry, regulatory and documentation context without dosing or treatment instructions.

Sources, Methodology & Last Verified

Official sources: ClinicalTrials.gov, NCBI PubMed, FDA, available PubChem records, and NOVABIO product and COA records.
Query retrieved: 2026-10-06T12:08:49Z
Inclusion: Exact identity terms and traceable registry, publication, chemistry, regulatory or catalogue fields.
Limitations: Search counts can include mixed evidence types and shared-name records; individual records require direct review.
Prepared by: NOVABIO Research
Reviewed date: 2026-10-06
Editorial methodology: How NOVABIO builds Research Profiles
Corrections contact: Contact NOVABIO with the page URL and source record.